optogenetics: a bright future for voltage gated ion channels · 2015. 7. 23. · optogenetics: a...

1
Optogenetics: A Bright Future for Voltage Gated Ion Channels Channelrhodopsin-2 (ChR2) is a light-activated microbial cation channel which can be used to depolarize neurons through the incidence of blue light (470 nm). The possibility to optically control the plasma membrane voltage opens new and interesting perspectives for the characterization of voltage-gated ion channels and the search for modulators. Proof of principle studies have been performed to verify the applicability of this tool for the development of cell based assays in High Throughput Screening (HTS) platforms as microplate readers. An HEK-293 cell line, which stably co-expresses the human voltage-gated calcium channel hCav1.3 and the inward rectifier hKir2.3 channel, was over-transfected with a ChR2 carrying a single amino acids mutation. This latter results in a prolonged lifetime of the conducting state of ChR2 and in a reduced light power requirement for its activation. A protocol of light stimulation of ChR2 and record of calcium ion influx through Cav1.3 with the use of a calcium-sensitive fluorescent dye (Fluo8) was tested in the Hamamatsu FDSSμcell. A well-known Cav1.3 blocker, Isradipine, tested in the resting and the partial inactivated Cav1.3 states, was used to confirm the pharmacological profile. Data obtained for the ChR2/hCav1.3 cell line by light stimulation have been also compared to the extracellular potassium stimulus and to patch- clamp to cross-check their reliability. Key-questions of the study Is the blue light produced by the FDSSμcell LED intense enough to activate ChR2? Can the light protocol be runned with the FDSSμcell? Is the activation of ChR2 sufficient to induce cell membrane depola- rization? Can the ChR2 be used to depolarize cells avoiding the irreversible depolarization protocols using KCl injection? Is the resulting membrane depolarization sufficient to activate the transfected voltage-gated channel Cav1.3? Can the cation flux through ChR2 disturbe the detction of Ca 2+ flux through the transfected target Cav1.3? Dihydropyridine Phenylalkylamine Benzothiazepin Membrane repolarization Time course of membrane repolarization after a first blue light pulse (MPdye) Cell membrane repolarization % 50 % repolarization Ca ++ influx through Cav1.3 Time course of signal recovery after a first blue light pulse (Fluo 8 NW) First pulse Second pulse F/F0 50 % inactivated Cav1.3 state-dependent blocker pharmacology Light vs. K + protocol Cav1.3/ChR2 @ qPatch 16x Resting (dark): IC 50 137 nM Resting (4 mM K + ): IC 50 95 nM Half-inact (Blue light 10 min): IC50 12 nM Half-inact (16 mM K + ): IC 50 14 nM Closed (HP = -90 mV): IC 50 362 nM Half-inact (HP = -60 mV): IC50 32 nM Isradipine IC 50 “K + protocol” “Light protocol” qPatch 16x Literature Resting 95 nM 137 nM 362 nM 300 nM (-90 mV) Half-inactivated 14 nM 12 nM 32 nM 30 nM (-50 mV) RATIO 6.8 11.4 11.3 10 Isradipine [M] 10 -10 10 -9 10 -8 10 -7 10 -6 10 -5 10 -4 0 2 4 6 8 Δ F/F0 (Fluo,8-N W) 10 -9 10 -8 10 -7 10 -6 10 -5 0 25 50 75 100 Isradipine [M] % Remaining ICav1.3 Electrode Micropipette Cell membrane Na + channel Low [K + ] O State-dependent blocker CLOSED Resting Resting Human KIR2.3 HEK-293 cells Fluo-8,NW ChR2 (D156A) Human Cav1.3 (α1, β3, α2δ1) Depolarized Depolarized INACTIVE OPEN DARK High [K + ] O BLUE LIGHT Vm (mV) -2.3 x 10 -10 -60 -40 -20 20 40 Charge ChR2 KIR2.3 Fluo 8 dye (4 mM K + ; 2 μM retinal) Blue light Blue light Blocker DR 10 min Fluo 8 dye (4 mM K + ; 2 μM retinal) Blue light Blocker DR 5 min Ca 2+ Cell membrane Vm (mV) Vh = -39.52 mV -100 -50 1.0 0.5 0.0 0 I/I max 0 mV 3000 ms 100 ms -100 mV -20 mV Hamamatsu Photonics Italia srl Strada della Moia 1 int 6 20020 Arese, Milano (Italy) Annamaria Mauro Laura Confalonieri Axxam SpA Via Meucci 3 20091 Bresso, Milano (Italy) Loredana Redaelli Jean-Francois Rolland Lia Scarabottolo Viviana Agus Stefan Lohmer Hamamatsu Photonics France Parc Du Mulin de Massy 19 Rue du Saule Trapu 91300 Massy (France) Jean Marc D’Angelo 150421_ham_poster_fdss_optogen_1000x1400mm.indd 1 21.04.15 16:58

Upload: others

Post on 26-Jan-2021

3 views

Category:

Documents


0 download

TRANSCRIPT

  • Optogenetics: A Bright Future for Voltage Gated Ion Channels

    Channelrhodopsin-2 (ChR2) is a light-activated microbial cation channel

    which can be used to depolarize neurons through the incidence of blue light

    (470 nm). The possibility to optically control the plasma membrane voltage

    opens new and interesting perspectives for the characterization of

    voltage-gated ion channels and the search for modulators.

    Proof of principle studies have been performed to verify the applicability

    of this tool for the development of cell based assays in High Throughput

    Screening (HTS) platforms as microplate readers.

    An HEK-293 cell line, which stably co-expresses the human voltage-gated

    calcium channel hCav1.3 and the inward rectifi er hKir2.3 channel, was

    over-transfected with a ChR2 carrying a single amino acids mutation. This

    latter results in a prolonged lifetime of the conducting state of ChR2 and

    in a reduced light power requirement for its activation.

    A protocol of light stimulation of ChR2 and record of calcium ion infl ux

    through Cav1.3 with the use of a calcium-sensitive fl uorescent dye (Fluo8)

    was tested in the Hamamatsu FDSSµcell. A well-known Cav1.3 blocker,

    Isradipine, tested in the resting and the partial inactivated Cav1.3 states,

    was used to confi rm the pharmacological profi le.

    Data obtained for the ChR2/hCav1.3 cell line by light stimulation have

    been also compared to the extracellular potassium stimulus and to patch-

    clamp to cross-check their reliability.

    Key-questions of the study

    Is the blue light produced by the FDSSµcell LED intense enough

    to activate ChR2? ➔ Can the light protocol be runned with the

    FDSSµcell?

    Is the activation of ChR2 suffi cient to induce cell membrane depola-

    rization? ➔ Can the ChR2 be used to depolarize cells avoiding the

    irreversible depolarization protocols using KCl injection?

    Is the resulting membrane depolarization suffi cient to activate the

    transfected voltage-gated channel Cav1.3?

    Can the cation fl ux through ChR2 disturbe the detction of Ca2+

    fl ux through the transfected target Cav1.3?

    Dihydropyridine

    Phenylalkylamine

    Benzothiazepin

    Membrane repolarizationTime course of membrane repolarization after a fi rst blue light pulse (MPdye)

    Cell membrane repolarization

    %

    50 % repolarization

    Ca++ infl ux through Cav1.3Time course of signal recovery after a fi rst blue light pulse (Fluo 8 NW)

    First pulse Second pulse

    ∆F/F

    0

    50 % inactivated

    Cav1.3 state-dependent blocker pharmacology Light vs. K+ protocol

    Cav1.3/ChR2 @ qPatch 16x

    Resting (dark): IC50 137 nMResting (4 mM K+): IC50 95 nMHalf-inact (Blue light�➔ 10 min): IC50 12 nMHalf-inact (16 mM K+): IC50 14 nM

    Closed (HP = -90 mV): IC50 362 nMHalf-inact (HP = -60 mV): IC50 32 nM

    Isradipine IC50 “K+ protocol” “Light protocol” qPatch 16x LiteratureResting 95 nM 137 nM 362 nM 300 nM (-90 mV)

    Half-inactivated 14 nM 12 nM 32 nM 30 nM (-50 mV)

    RATIO 6.8 11.4 11.3 10

    10- 9 10- 8 10- 7 10- 6 10- 50

    25

    50

    75

    100

    Isradipine [M]Isradipine [M]

    % R

    emai

    ning

    ICav

    1.3

    10- 1 0 10- 9 10- 8 10- 7 10- 6 10- 5 10- 4

    0

    2

    4

    6

    8

    ∆ F/

    F0 (F

    luo,

    8-N

    W)

    13

    10- 9 10- 8 10- 7 10- 6 10- 50

    25

    50

    75

    100

    Isradipine [M]Isradipine [M]

    % R

    emai

    ning

    ICav

    1.3

    10- 1 0 10- 9 10- 8 10- 7 10- 6 10- 5 10- 4

    0

    2

    4

    6

    8

    ∆ F/

    F0 (F

    luo,

    8-N

    W)

    13

    Electrode

    Micropipette

    Cell membrane Na+ channel

    Low [K+]O

    State-dependent blocker

    CLOSED

    Resting

    Resting

    HumanKIR2.3

    HEK-293 cells

    Fluo-8,NW

    ChR2(D156A)

    Human Cav1.3(α1, β3, α2δ1)

    Depolarized

    Depolarized

    INACTIVEOPEN

    DARK

    High [K+]O

    BLUE LIGHT

    Vm (mV)

    -2.3 x 10-10

    -60 -40 -20 20 40

    Char

    ge

    ChR2

    KIR2.3

    Fluo 8 dye(4 mM K+; 2 µM retinal)

    Blue lightBlue light Blocker DR

    10 min

    Fluo 8 dye(4 mM K+; 2 µM retinal)

    Blue lightBlocker DR

    5 min

    Ca2+

    Cell membrane

    Vm (mV)

    Vh = -39.52 mV

    -100 -50

    1.0

    0.5

    0.00

    I/Im

    ax

    0 mV3000 ms

    100 ms

    -100 mV

    -20 mV

    Hamamatsu Photonics Italia srlStrada della Moia 1 int 6

    20020 Arese, Milano (Italy)

    Annamaria Mauro Laura Confalonieri

    Axxam SpAVia Meucci 3

    20091 Bresso, Milano (Italy)

    Loredana Redaelli Jean-Francois Rolland Lia Scarabottolo Viviana Agus Stefan Lohmer

    Hamamatsu Photonics FranceParc Du Mulin de Massy

    19 Rue du Saule Trapu

    91300 Massy (France)

    Jean Marc D’Angelo

    150421_ham_poster_fdss_optogen_1000x1400mm.indd 1 21.04.15 16:58